<SEC-DOCUMENT>0001140361-23-046302.txt : 20231002
<SEC-HEADER>0001140361-23-046302.hdr.sgml : 20231002
<ACCEPTANCE-DATETIME>20231002160559
ACCESSION NUMBER:		0001140361-23-046302
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20231002
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231002
DATE AS OF CHANGE:		20231002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROCKET PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001281895
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36829
		FILM NUMBER:		231299636

	BUSINESS ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 7530
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118
		BUSINESS PHONE:		646-440-9100

	MAIL ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 7530
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INOTEK PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20040226
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20011759_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:rckt="http://rocketpharma.com/20231002" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_f5607ff47e364055875cf5b157d79509" contextRef="c20231002to20231002" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_0a41bfac0ff04c39b5224e7f322297eb" contextRef="c20231002to20231002">0001281895</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="rckt-20231002.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20231002to20231002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001281895</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-02</xbrli:startDate><xbrli:endDate>2023-10-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, DC 20549</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_ef1be5b1b97d4cd9a0f744636188a1b2" contextRef="c20231002to20231002">8-K</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
<div>Date of Report (Date of earliest event reported):&#160; <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_65609a9f7f8c43cfbdc1081e9e8bdda4" contextRef="c20231002to20231002" format="ixt:date-monthname-day-year-en">October 2, 2023</ix:nonNumeric></div>

        <div><br />
        </div>

      </div>

      <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span></div>

        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" />
<div><span style="font-size: 10pt;"> </span></div>
</div>

      <div><span style="font-size: 10pt;"><br />
      </span></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_0f04e793993f4515985f8ab6b8cc2b8a" contextRef="c20231002to20231002">Rocket Pharmaceuticals, Inc.</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span></div>

        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" />
<div><span style="font-size: 10pt;"> </span></div>
</div>

      <div> <br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.3%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_32763620f6984f11a7d104b58c3ece30" contextRef="c20231002to20231002" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 34%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_32198309517b4312acc25ae8e439a0ac" contextRef="c20231002to20231002">001-36829</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 32.7%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_4537b7680fc944af9b16edbdcaee0990" contextRef="c20231002to20231002">04-3475813</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(State or other jurisdiction of incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Commission File Number)</div>
            </td>

    <td style="width: 32.7%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.01%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_af7c375a3ed140988c61191013df0baa" contextRef="c20231002to20231002">9 Cedarbrook Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_dfc419b0555e4c28906a6a61d2396067" contextRef="c20231002to20231002">Cranbury</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_7bf679ac8c91416093a3ea05cf749803" contextRef="c20231002to20231002">NJ</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_5142374f89164529a88921d2090aaa7f" contextRef="c20231002to20231002">08512</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.01%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(</span><span style="font-size: 10pt;">Address of principal
                  executive offices)</span></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div> <br />
      </div>

      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /> </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
<div>Registrant&#8217;s telephone number, including area code:&#160; (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_4dbca186b5c04f2d8ddb991b8fed6d56" contextRef="c20231002to20231002">646</ix:nonNumeric>)
        <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_05c09fdcac9648ba83997907a2932851" contextRef="c20231002to20231002">440-9100</ix:nonNumeric></div>

        <div><br />
        </div>

      </div>

      <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span></div>

        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" />
<div><span style="font-size: 10pt;"> </span></div>
</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not applicable</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
        following provisions (see General Instruction A.2):</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_8e58aa90c70a475fa0c0aef399ab8021" contextRef="c20231002to20231002" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_aa43ce9f40d049e9ad3272c755b39c73" contextRef="c20231002to20231002" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_514532bb83a6401b9a2c3f4519e68774" contextRef="c20231002to20231002" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_b641dfcb79a44a819e70f3243a7ae0ac" contextRef="c20231002to20231002" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 34.99%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title of each class</div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 30%; vertical-align: middle; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Trading</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Symbol(s)</div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 33%; vertical-align: middle; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Name of each exchange on which</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 34.99%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_a546c898d5614aecbb0b489e25792c59" contextRef="c20231002to20231002">Common stock, $0.01 par value</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 30%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_3acad9c1e7854a43a59c4b547c8eb6aa" contextRef="c20231002to20231002">RCKT</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 33%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_2e428acabc4d4c609598afffe4d4e992" contextRef="c20231002to20231002" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this
        chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_2aefaaba153a4569a9ac92ab9293060c" contextRef="c20231002to20231002" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
        or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 8.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Other Events.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">On October 2, 2023, Rocket Pharmaceuticals, Inc. (the &#8220;Company&#8221;) announced that the U.S.
          Food and Drug Administration has accepted the Biologics License Application and granted Priority Review for </span><span style="font-size: 10pt;">KRESLADI (RP-L201; marnetegragene autotemcel), a lentiviral vector-based investigational gene
          therapy for severe Leukocyte Adhesion Deficiency-1.<span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> A copy of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on
            Form 8-K and is incorporated into this report by reference.</span></span></div>

      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>

    <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Exhibits</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 10%; vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Exhibit No.</div>
            </td>

    <td style="width: 90%; vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: left; font-family: 'Times New Roman';"><a href="ef20011759_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 90%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Press Release of Rocket Pharmaceuticals, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: left; font-family: 'Times New Roman';">104</div>
            </td>

    <td style="width: 90%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; text-indent: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
        behalf by the undersigned hereunto duly authorized.</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.91%; vertical-align: top; font-size: 10pt;"><br />
            </td>

    <td colspan="2" style="width: 50.09%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Rocket Pharmaceuticals, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: bottom; font-size: 10pt;"><br />
            </td>

    <td style="width: 3.21%; vertical-align: bottom; font-size: 10pt;"><br />
            </td>

    <td style="width: 46.88%; vertical-align: bottom; font-size: 10pt;"><br />
            </td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Date: October 2, 2023</div>
            </td>

    <td style="width: 3.21%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
            </td>

    <td style="width: 46.88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Martin Wilson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: top; font-size: 10pt;"><br />
            </td>

    <td style="width: 3.21%; vertical-align: bottom; font-size: 10pt;"><br />
            </td>

    <td style="width: 46.88%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Martin Wilson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: top; font-size: 10pt;"><br />
            </td>

    <td style="width: 3.21%; vertical-align: bottom; font-size: 10pt;"><br />
            </td>

    <td style="width: 46.88%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">General Counsel and Chief Compliance Officer, SVP</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">
        <div><br />
        </div>

        <div><br /></div>

        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20011759_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 99.1</div>
    <div style="text-align: left; font-size: 10pt;"><img height="55" width="132" src="image00002.jpg"></div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Rocket Pharmaceuticals Announces FDA Acceptance of Biologics License Application with
        Priority Review for RP-L201 (marnetegragene autotemcel)</font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)</font></font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Prescription Drug User Fee Act (PDUFA) target action date is March 31, 2024</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</font><font style="font-size: 10pt;">RP-L201 has received FDA Regenerative Medicine<font style="font-family: 'Times New Roman';"> Advanced Therapy (RMAT), Rare Pediatric, Fast Track and Orphan Drug designations; Rocket eligible for Priority Review Voucher, if RP-L201 is approved</font></font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">CRANBURY, N.J. </font><font style="font-size: 10pt;">&#8211; <font style="font-family: 'Times New Roman'; font-weight: bold;">Oct. 2, 2023 </font>&#8211; <u><font style="font-family: 'Times New Roman';">Rocket Pharmaceuticals, Inc.</font></u> (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an
        integrated and sustainable pipeline of genetic therapies for rare&#160; disorders with high unmet need, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted Priority Review for
        RP-L201 (marnetegragene autotemcel), a lentiviral vector (LV)-based investigational gene therapy for severe Leukocyte Adhesion Deficiency-I (LAD-I), a rare genetic immune disorder that predisposes patients to recurrent and fatal infections and is
        near-uniformly fatal in childhood without an allogeneic hematopoietic stem cell transplant. The PDUFA date set by the FDA is March 31, 2024.</font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Today&#8217;s acceptance of the BLA by the FDA marks a significant milestone for Rocket towards our goal of delivering a one-time gene therapy to patients facing the devastating
      effects of severe LAD-I. For these patients, survival beyond childhood is uncommon. Bone marrow transplant is currently the only treatment option, has substantial morbidity and mortality, and may not be available in time for these children,&#8221; said
      Kinnari Patel, Pharm<font style="font-family: 'Times New Roman';">.</font>D<font style="font-family: 'Times New Roman';">.</font>, MBA, President and Chief Operating Officer, Rocket Pharma. &#8220;We are incredibly grateful to the
      patients, caregivers and researchers who have shared this journey with us and look forward to continuing our close collaboration with the FDA during the review period as we work to bring RP-L201 to patients as quickly as possible.&#8221;</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Positive top-line data from the global Phase 1/2 study of RP-L201 demonstrated 100% overall survival at 12 months post-infusion (and for the entire duration of follow-up)
      for all nine LAD-I patients with 12 to 24 months of available follow-up. Data also showed large decreases compared with pre-treatment history in the incidences of significant infections, combined with evidence of resolution of LAD-I-related skin
      lesions and restoration of wound repair capabilities. All primary and secondary endpoints were met, and RP-L201 was very well tolerated in all patients with no treatment related SAEs.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;As the Principal Investigator in the U.S., I oversaw treatment of six of the nine LAD-I patients in this trial. In my opinion, the results are remarkable. All of these
      children have been in good health with no significant LAD-I-related infections or inflammatory skin lesions since treatment. Based on what I see, they are all experiencing a normal childhood life, which is the goal of this type of potentially
      curative gene therapy,&#8221; said Donald B. Kohn, M.D., Distinguished Professor of Microbiology, Immunology &amp; Molecular Genetics, Pediatrics, and Molecular &amp; Medical Pharmacology at University of California, Los Angeles (UCLA) and Director of the
      UCLA Human Gene and Cell Therapy Program.</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <div style="text-align: left; font-size: 10pt;"><img height="55" width="132" src="image00002.jpg"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About RP-L201 (marnetegragene autotemcel)</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">RP-L201 is an investigational gene therapy that contains autologous (patient-derived)
        hematopoietic stem cells that have been genetically modified with a lentiviral vector to deliver a </font><font style="font-size: 10pt; font-family: 'Times New Roman';">functional copy of the </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">ITGB2</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> gene, which encodes for the beta-2 integrin component CD18, a key protein that facilitates leukocyte adhesion and enables their
        extravasation from blood vessels to fight infection. Rocket holds FDA Regenerative Medicine Advanced Therapy (RMAT), Rare Pediatric, and Fast Track designations in the U.S., PRIME and Advanced Therapy Medicinal Product (ATMP) designations in the
        EU, and Orphan Drug designation in both regions for the program.&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">RP-L201</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> was in-licensed from the Centro de Investigaciones Energ&#233;ticas, Medioambientales y Tecnol&#243;gicas (CIEMAT), Centro de Investigaci&#243;n Biom&#233;dica en Red de Enfermedades Raras and Instituto de
        Investigaci&#243;n Sanitaria Fundaci&#243;n Jim&#233;nez D&#237;az. The lentiviral vector was developed in a collaboration between UCL and CIEMAT.</font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Leukocyte Adhesion Deficiency-I</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Severe Leukocyte Adhesion Deficiency-I (LAD-I) is a rare, autosomal recessive pediatric disease caused by mutations in the <font style="font-family: 'Times New Roman'; font-style: italic;">ITGB2</font> gene encoding for the beta-2 integrin component CD18. CD18 is a key protein that facilitates leukocyte adhesion and extravasation from blood vessels to combat infections. As a result, children with
      severe LAD-I are often affected immediately after birth. During infancy, they suffer from recurrent life-threatening bacterial and fungal infections that respond poorly to antibiotics and require frequent hospitalizations. Children who survive
      infancy experience recurrent severe infections including pneumonia, gingival ulcers, necrotic skin ulcers, and septicemia. Without a successful bone marrow transplant, survival beyond childhood is rare. LAD-I is estimated to impact an estimated 800
      to 1,000 individuals in the U.S. and Europe. Currently the only potential curative treatment is an allogeneic hematopoietic stem cell transplant, which may not be available in time for these children and itself has substantial morbidity and
      mortality. There is a high unmet medical need for patients with severe LAD-I.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Rocket&#8217;s LAD-I research is made possible by a grant from the California Institute for Regenerative Medicine (Grant Number CLIN2-11480). The contents of this press release
      are solely the responsibility of Rocket and do not necessarily represent the official views of CIRM or any other agency of the State of California.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Rocket Pharmaceuticals, Inc.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is advancing an integrated and sustainable pipeline of investigational genetic therapies designed to correct the root cause of
        complex and rare disorders. The Company&#8217;s platform-agnostic approach enables it to design the best therapy for each indication, creating potentially transformative options for patients afflicted with rare genetic diseases. Rocket's clinical
        programs using lentiviral vector (LV)-based gene therapy are for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe
        pediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, and Pyruvate Kinase Deficiency (PKD), a rare, monogenic red blood cell disorder resulting in increased red cell destruction and mild to
        life-threatening anemia. Rocket&#8217;s first clinical program using adeno-associated virus (AAV)-based gene therapy is for Danon Disease, a devastating, pediatric heart failure condition. Rocket also is developing AAV-based gene therapy programs in
        PKP2-<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">a</font>rrhythmogenic cardiomyopathy<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> (ACM)</font> and BAG3-associated dilated
        cardiomyopathy (DCM). For more information about Rocket, please visit <u><font style="font-family: 'Times New Roman';">www.rocketpharma.com</font><font style="font-family: 'Times New Roman'; color: rgb(5, 99, 193);">.</font></u></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(5, 99, 193);"><u> <br>
          </u></font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <div style="text-align: left; font-size: 10pt;"><img height="55" width="132" src="image00002.jpg"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Rocket Cautionary Statement Regarding Forward-Looking Statements</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Various statements in this release concerning Rocket&#8217;s future expectations, plans and prospects, including without limitation, Rocket&#8217;s expectations regarding the safety
      and effectiveness of product candidates that Rocket is developing to treat Fanconi Anemia (FA), Leukocyte Adhesion Deficiency-I (LAD-I), Pyruvate Kinase Deficiency (PKD), Danon Disease (DD) and other diseases, the expected timing and data readouts of
      Rocket&#8217;s ongoing and planned clinical trials, the expected timing and outcome of Rocket&#8217;s regulatory interactions and planned submissions, Rocket&#8217;s plans for the advancement of its Danon Disease program, including its planned pivotal trial, and the
      safety, effectiveness and timing of related pre-clinical studies and clinical trials, may constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995 and other
      federal securities laws and are subject to substantial risks, uncertainties and assumptions. You should not place reliance on these forward-looking statements, which often include words such as "believe," "expect," "anticipate," "intend," "plan,"
      "will give," "estimate," "seek," "will," "may," "suggest" or similar terms, variations of such terms or the negative of those terms. Although Rocket believes that the expectations reflected in the forward-looking statements are reasonable, Rocket
      cannot guarantee such outcomes. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, Rocket&#8217;s ability to monitor the impact of COVID-19
      on its business operations and take steps to ensure the safety of patients, families and employees, the interest from patients and families for participation in each of Rocket&#8217;s ongoing trials, our expectations regarding the delays and impact of
      COVID-19 on clinical sites, patient enrollment, trial timelines and data readouts, our expectations regarding our drug supply for our ongoing and anticipated trials, actions of regulatory agencies, which may affect the initiation, timing and progress
      of pre-clinical studies and clinical trials of its product candidates, Rocket&#8217;s dependence on third parties for development, manufacture, marketing, sales and distribution of product candidates, the outcome of litigation, and unexpected expenditures,
      as well as those risks more fully discussed in the section entitled "Risk Factors" in Rocket&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, filed February 28, 2023&#160; with the SEC and subsequent filings with the SEC including our
      Quarterly Reports on Form 10-Q.&#160; Accordingly, you should not place undue reliance on these forward-looking statements. All such statements speak only as of the date made, and Rocket undertakes no obligation to update or revise publicly any
      forward-looking statements, whether as a result of new information, future events or otherwise.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Media</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">Kevin Giordano</div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><u>media@rocketpharma.com</u></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investors</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Brooks Rahmer</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>investors@rocketpharma.com</u></div>
    <div style="text-align: left; font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-size: 10pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rckt-20231002.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.9.1.5178 Broadridge-->
<xs:schema targetNamespace="http://rocketpharma.com/20231002" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:rckt="http://rocketpharma.com/20231002" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="rckt-20231002_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="rckt-20231002_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://rocketpharma.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rckt-20231002_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.9.1.5178 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rckt-20231002_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.9.1.5178 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://rocketpharma.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="rckt-20231002.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://rocketpharma.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !3 ,8# 2(  A$! Q$!_\0
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M(K/44^R7CD*K#F.0GT]#['\Z[FM8S4E='#6H5*,N6HK!1115&04444 %%%%
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M110 44A(4$DX Y)-<UX>\>Z#XGU2ZT[3+B1Y[8%COC*AU!P2I[C- '34444
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D !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140645670128160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 02, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  02,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Rocket Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001281895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3475813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9 Cedarbrook Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cranbury<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">440-9100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RCKT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>ef20011759_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rckt-20231002.xsd" xlink:type="simple"/>
    <context id="c20231002to20231002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001281895</identifier>
        </entity>
        <period>
            <startDate>2023-10-02</startDate>
            <endDate>2023-10-02</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20231002to20231002"
      id="Fact_f5607ff47e364055875cf5b157d79509">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20231002to20231002"
      id="Fact_0a41bfac0ff04c39b5224e7f322297eb">0001281895</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20231002to20231002"
      id="Fact_ef1be5b1b97d4cd9a0f744636188a1b2">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20231002to20231002"
      id="Fact_65609a9f7f8c43cfbdc1081e9e8bdda4">2023-10-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20231002to20231002"
      id="Fact_0f04e793993f4515985f8ab6b8cc2b8a">Rocket Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20231002to20231002"
      id="Fact_32763620f6984f11a7d104b58c3ece30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20231002to20231002"
      id="Fact_32198309517b4312acc25ae8e439a0ac">001-36829</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20231002to20231002"
      id="Fact_4537b7680fc944af9b16edbdcaee0990">04-3475813</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20231002to20231002"
      id="Fact_af7c375a3ed140988c61191013df0baa">9 Cedarbrook Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20231002to20231002"
      id="Fact_dfc419b0555e4c28906a6a61d2396067">Cranbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20231002to20231002"
      id="Fact_7bf679ac8c91416093a3ea05cf749803">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20231002to20231002"
      id="Fact_5142374f89164529a88921d2090aaa7f">08512</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20231002to20231002"
      id="Fact_4dbca186b5c04f2d8ddb991b8fed6d56">646</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20231002to20231002"
      id="Fact_05c09fdcac9648ba83997907a2932851">440-9100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20231002to20231002"
      id="Fact_8e58aa90c70a475fa0c0aef399ab8021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20231002to20231002"
      id="Fact_aa43ce9f40d049e9ad3272c755b39c73">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20231002to20231002"
      id="Fact_514532bb83a6401b9a2c3f4519e68774">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20231002to20231002"
      id="Fact_b641dfcb79a44a819e70f3243a7ae0ac">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20231002to20231002"
      id="Fact_a546c898d5614aecbb0b489e25792c59">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20231002to20231002"
      id="Fact_3acad9c1e7854a43a59c4b547c8eb6aa">RCKT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20231002to20231002"
      id="Fact_2e428acabc4d4c609598afffe4d4e992">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20231002to20231002"
      id="Fact_2aefaaba153a4569a9ac92ab9293060c">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MVA"T%Q951@K7F4G_#=Q[NF&P9GV>:>'#;-[ *O:;"&:WP.Q>@SF&654L!-6
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M4$L! A0#%     @ O8!"5WZ8$%[N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ O8!"5YE<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " "]@$)7_0Q:P58$  "3$   &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ O8!"5Y^@&_"Q @  X@P
M  T              ( !F0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "]
M@$)7EXJ[',     3 @  "P              @ %U#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " "]@$)7'#AEZC\!   \ @  #P              @ %>$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ O8!"5R0>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ O8!"5V60>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20011759_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rocketpharma.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20011759_8k.htm">ef20011759_8k.htm</File>
    <File>rckt-20231002.xsd</File>
    <File>rckt-20231002_lab.xml</File>
    <File>rckt-20231002_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20011759_8k.htm": {
   "nsprefix": "rckt",
   "nsuri": "http://rocketpharma.com/20231002",
   "dts": {
    "inline": {
     "local": [
      "ef20011759_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "rckt-20231002.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rckt-20231002_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rckt-20231002_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://rocketpharma.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20231002to20231002",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20011759_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231002to20231002",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20011759_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-23-046302-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-23-046302-xbrl.zip
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M[*L7\W\F[CK@,";#'.I43VO$\QHUW5,+6>KG79GMU;]5-78EJP OX7"<I@.
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M+_+&OP'M+A1P3Q-A*1+-%AJLC\YA*S&^3"G_D0D)*UE%'4=)&7S+:YHYX%Y
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ML;N"WMD0!ELQW"(>>F$7\!K:RDQ<J*2""+:.?]T>S"21>UU<*%?I!2\ 3_
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M@W"E.N5"%;.CH(7UZ-L0O(U4\-9<[>M$:8U!(*Y-_8F^S^\B_?6]'W[[E!9
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M,-^JHP<8I2DE?<,O2;EK_>S^?DE*N^-X]>(1_7(9O@B_+N?_ %!+ P04
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M.7O7X]GYOV6?F;\QW;=:&7&/HTKLZ@]02P,$%     @ O8!"5Y-R1@A_"
M=%@  !4   !R8VMT+3(P,C,Q,# R7VQA8BYX;6S-G&MOVS84AK\/V'_@O"\;
M4-NUC5T2-"ZRM"F"I4F0I-@-0R%+M"-,%@-*;IQ_/U(2;9$\I)2*DO6E=7C>
M\_+V'$E6(KUYNUU'Z NF24CBD\%D]'J <.R3((Q7)X--,O02/PP';^???O/F
MN^'P XXQ]5(<H,4S^HT2+Z!AL,+HYO9Z&48836>CH]%D]-/DEU]+X>&0IT=A
M_-\Q_V?A)1BQ;N/D>)N$)X.'-'T\'H^?GIY&3[,1H:OQ]/7KR?C/CY=W_@->
M>\,P3E(O]O$ ,?UQDC5>$M]+LS&7TK<+&@F#V7C7EU'!?QH*V9 W#2?3X6PR
MVB;!H!@B#]?H1,BWFKZ8T^3HZ&B<17=29A1:K'?39JN'4+Y^E$3X%B\1___3
M[84Q^VC,%>,8IY?> D>LRRP]?7[$)X,D7#]&6+0]4+R$?2)*=S9\=8[XZDQ^
MYJOS_=YYW&1X*P[3/4F]R,TX,S]]K%HWS0=]Y6II;4.^<KG*K,AQ!ZM<ZJ;Y
MH&\P#4GP/@[:'[C:E:O!WZ4>[0 5O;/F$VA_U,!0(]YTR3Y)_>)MBN, !Z)G
M[FTY=F9=9P?;S'GG37S)->)G$4+UZ23,-7-,L#]:D2_C (?,>3KC'X;\0S8+
M]L/G,\).GZ>+)*6>GPJG;!(G S"6ABD?NQ(;RP/E^=)0*4[(AOI8Z4$;P>=H
M$;UHD:0]SH=F,EU'K%M^88#CX:>[ 0H#DW:>-:%_1.._;\;[4>LS/:7ROGC4
M%T-B'RNF42C&/F$GR\=T*,UH2<G:M ^D8OF*U<C\CI$D0RE!AMQQZ\2](_YF
MC>/TGCDJ.$"A8AIRJ %N92-7M &>)M@TZ5RT(-YT6-# ]2?V=9,Q*ZL$97IF
M^Y#]0<.4'7+/R'J]B</\8CM1:+!JBFD9- WX QU=@6@S-Q%ISID7(23'#LNH
M?==(S466J07E E^+5_L<WY$H],.4?9_]R"XX:.A%"E)F03%%2-  7]W.%;M&
M9Q.XAH3YOAV)P&&1M>P1J;.J,JRZ5I!J<FD?TQN*>7U@M@39D9Y?[-+KY1)3
M!:%J83%9F[ !OF9;5QA7]F#"N2)QSN)#OR1 N0)EDL,"7F-7R4O67P;>G"/
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M/]4.HHHDY2N4:1&AJ- CGM"'@JH'!/FJ'8.*RYHLEUB-?KHJM/=K3%=AO/I
MR5/Z<$;6CUX,7^Q;E5)A&92-"PKT=5M(MB[L!63.%(4C%"B7H$+3AUJQ[RUY
MT29 M0$FR35A\>VJ%DZ#@#&8%/]=AC&>@)5@T4EU .H:5P'@ZK8&S!W8*\"4
M)_@O J_$!\0EZ#KNQ=G"MJ?D!<L/T0^DR.P;/0]'_K0F^=.:Y$];(7_:-OG3
MKR1_6H/\^R?23_*G=<F?OIS\:17YTT.3/ZM)_JPF^;-6R)^U3?[L*\F?U2&?
M;5A/C_JSNNS/7L[^K(K]V4'8/V,?K^D]>8IMY.LJB/NRRA7U>\]6F-?L:Q&O
M9&F\\SC_5LP5/2(=V$6(<WC)+93O$T#&5;^."<^^8E_3&TJ^A+$&7!TIQ+HF
M=06\8MP*]7 ?M="'4C7^=[>%A*Q'16#:8Z@2+'MA*0<E"ZP)T+GK0W]^V\EZ
MW)<EX$%?2)P=\7/#=@[WDG>]8WTI13_0Y\$>X:WN&'B UU?8=G0O;NV"A_:R
M4\?XWI D]:*_PT?C;P5L0@AE1>@*:,FV%:RA'FK!K2=JB.<2Q#2]N;EOW5<(
M>.,.6+"7<D#X =?V2X!?3)U2[ '00Z%B@G*HR5L?2D;.7OJ@>QK?^:!*Y]FE
M-F_J 9W@!A#[PLD$EE6[MSUHF>U3QE]T%=T\D!C^VQE3N)B,'FY G&KFBCJ#
MKXD\4#[/6E'6W(N_)C!N#*E>3)E$52EHA!TZ>*(>^QO**F$R7=SS@2JDF,+%
MI/1PDV?I%3-G3]+#OL;GZ"'Y//N(R!)-IC\L?D1"=. GZ4V[0ZI75,925>Z>
MH0<=VL?RBMQ3C[^W\.YYO2 1\ BD15%,#50TX!/P<X6HV=I$J2EC?D50$4%Y
MJ </2MKVBM1:7)E60"R -?JTSZS4L<(/&"LFI<0:$"HYN6(3,C51J6OG,HR'
MY1#>!5*Q>#)[DDQ0!^1V=^I^O_4?V&9@X($8FT0YA<L2!Z?QLJ'K4SG@774Z
MUU+F(H)$J </Q%@WC-1;8/C,7E:K9W?=J7B'8VDM+MDG_N;?HBG,WY0[_Q]0
M2P,$%     @ O8!"5\;5JPO>!0  ^3X  !4   !R8VMT+3(P,C,Q,# R7W!R
M92YX;6S56UMOXC@4?E]I_T.6?88TL'.A:F?4[;0CM$Q;E:[V\K(RB0&K28R<
M4.B_7SO8%#NV$Z;MZ/2%2\[GX_/Y^W([A)//FRP-'C K",U/.U'OJ!/@/*8)
MR>>GG571145,2.?SIY]_.OFEV_V*<\Q0B9-@^AC\SBA*&$GF.+BYO9Z1% ?]
M06_8BWKOH@\?]\+=KAB>DOS^6+Q,48$#/FU>'&\*<MI9E.7R. S7ZW5O/>A1
M-@_[1T=1^/>W\21>X QU25Z4*(]Q)^#XXZ+:.*8Q*JN:]X9OIBQ5"0;A;BXG
M0GSK*EA7;.I&_>X@ZFV*I"-+%.$6DRCXIH:7G*+A<!A6T1V4)R*>U#O:?/6"
M8+M^C*;X%L\"\?[G[<@Y>A@*1)CC<HRF..535L/+QR4^[10D6Z98;5LP/+/G
M21G;I1&K,Q2K$[T7J_/K4^;P.>7-A9GN:(G2EZFSRE>OM3;-\XN^>JFE]95\
M]9*KS'=R_ -6>6^:YQ=]@QFAR46>O'[AYE0O5?RD1.P'6*4^V?,)O'[5!Y3*
M:'R/R^4"L0SU8IIMTW^A\2K#>7F6<^E*4CZ.\AGE"'%N:*Z<Q??BR-8?1$='
M_:HN?[[].I<,%QQ81<9\@S89WI0X3W"BIA.U/H=)-:^:.:6Q-EDJSH64U44I
M^&25(@6.>W/Z$":8A(*N^%#QKCCS+_^=4WX1<#8M2H;B4F5*A3JG'6N,5R@H
M&;'PU0M5RW3',QIUVD*R3#VD5[DOY!G3*T8L5IGX1TW%^@E;(L(E8CQ?-UZ0
M=&> &:.9:R6IM_3]\HX#+4-0TD ?25F"V6GG2%S'\8$SS)C<R3QU5T6G^WOB
M:PIXQJM-1,67*9H;"EIC<AV,&#P-?<4WB&@,E2I&@%54MMN=-;_PP[EC?[1B
MC!W3P,!3MPV9EKNJD4*JW7\#:E^2(D;I/QBQ2[ZE<.CM0!F*UU!P-?<3:JEZ
M+8G4??!F=-_ZMEEY"\ZJO8:#KKZ;U$'Z:VFD WX#[(#MI>@E2?'5*IMB9@CO
M"LNEJ8?AR=Q H4'=^F@IZCOPHM[B.1%$\O(*9>:YVP?1Q#4A4 7V4FDELIE!
M"OT>O-#GG!I#Z8C?D&[^P(]6I1T83>H:!JK6?C*MQ*ZED&I_ *_V*(\I6U)6
M\9MPFOB<KCB9QW.:V/?R5B,T)S2,@.J+0XBV<DE#0NF9C^ ]<X<VHX2S)3.R
M_5G%<[)OP&H^<6*A.J0=N5;><*:2KAB"=\59DG"BA7P;DQQ'5D=X<)H;K#BH
M3F@FU<H%UC2JOP.Y3><JO]_2 OV6%NB_)0N8I+[3 OTG"T#N\;G*'[2TP*"E
M!09OR0(FJ>^TP.#) I ;?UKYY_SC-;NCZ]QG@#K*)O\^"KCX3D*'2+^?1 D/
MN?.G%5]=V5ZS&T8?R/8Y'*?Z#JC- C4H<!_XJ1UBAEHFY0CXG4!EY^UMCO<X
MH$.L!P$% :Z\G<I!N[_*H)2&WQZ4E=_0HD3IOV3I;!_X@#;5#2!P[7VT#G&
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MY_;23L+:$H[Y!O'W\VU$O(B_:W_Z'U!+ 0(4 Q0    ( +V 0E=2-G&_31(
M /=\   1              "  0    !E9C(P,#$Q-S4Y7SAK+FAT;5!+ 0(4
M Q0    ( +V 0E?3IZDQ?!0  #='   5              "  7P2  !E9C(P
M,#$Q-S4Y7V5X.3DM,2YH=&U02P$"% ,4    " "]@$)7X T!'$<#  !%#P
M$0              @ $K)P  <F-K="TR,#(S,3 P,BYX<V102P$"% ,4
M" "]@$)7DW)&"'\(  !T6   %0              @ &A*@  <F-K="TR,#(S
M,3 P,E]L86(N>&UL4$L! A0#%     @ O8!"5\;5JPO>!0  ^3X  !4
M         ( !4S,  ')C:W0M,C R,S$P,#)?<')E+GAM;%!+!08     !0 %
+ $<!  !D.0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
